MDT perspectives on approaches for the use of immune checkpoint inhibitor therapy in patients with solid tumours

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team evaluate the strategies for identifying and monitoring immune-related adverse events.

The multidisciplinary team:

• Medical oncologist: Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan
• Oncology nurse: Ms Tara Hurley, Royal Marsden NHS Foundation Trust, Sutton, UK
• Clinical oncology pharmacist: Dr Alison Palumbo, Oregon Health and Science University, Oregon, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from MSD. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/immune-checkpoint-inhibitors-in-solid-tumours/